<DOC>
	<DOCNO>NCT01649843</DOCNO>
	<brief_summary>Achalasia rare esophageal motility disorder , characterize clinically symptoms dysphagia , regurgitation , weight loss chest pain . These symptom primarily cause incomplete relaxation frequently hypertensive low esophageal sphincter ( LES ) extent lack peristalsis tubular esophagus . Unfortunately , therapy return normal esophageal function . Treatment therefore direct lower LES pressure , aim reduce functional obstruction bolus transit site . Current treatment endoscopic surgical . Peroral endoscopic myotomy ( POEM ) recently describe new minimally invasive endoscopic myotomy technique intend permanent cure primary achalasia center . The investigator purpose evaluate efficacy feasibility POEM patient achalasia prospective large study .</brief_summary>
	<brief_title>Clinical Impact Peroral Endoscopic Myotomy Esophageal Achalasia</brief_title>
	<detailed_description>1 . Patients eligible enrollment study Eckardt symptom score ≥ 4 . The diagnosis achalasia make basis absence peristalsis impaired relaxation LES establish method ( barium swallow , manometry , esophagogastroduodenoscopy ( EGD ) ) . Exclusion criterion severe cardiopulmonary disease serious disease lead unacceptable surgical risk , pseudoachalasia , megaesophagus ( diameter &gt; 7 cm ) . 2 . All patient schedule follow-up visit 1 month POEM EGD manometry . Symptoms assess 1 month treatment clinic every 3 month thereafter via telephone questionnaire . 3 . The primary outcome study therapeutic success ( reduction Eckardt score ≤3 ) follow-up assessment . The secondary outcome include procedure-related adverse event , LES pressure manometry pre- post POEM , reflux symptom medication use POEM , procedure-related parameter procedure time , hospital stay , myotomy length .</detailed_description>
	<mesh_term>Esophageal Achalasia</mesh_term>
	<criteria>Eckardt symptom score ≥ 4 The diagnosis achalasia make basis absence peristalsis impaired relaxation LES establish method ( barium swallow , manometry , esophagogastroduodenoscopy ) Informed patient consent obtain Severe cardiopulmonary disease serious disease lead unacceptable surgical risk Pseudoachalasia megaesophagus ( diameter &gt; 7 cm )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Peroral endoscopic myotomy</keyword>
	<keyword>Esophageal Achalasia</keyword>
</DOC>